Deficiency Diseases  >>  odanacatib (MK-0822)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
odanacatib (MK-0822) / Merck (MSD)
NCT00242476: A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)

Completed
2
216
US
MK0822A
Merck Sharp & Dohme LLC
Vitamin D Deficiency
07/06
07/06

Download Options